Your browser doesn't support javascript.
loading
The accuracy of fully-automated algorithms for the surveillance of central venous catheter-related bloodstream infection in hospitalised patients.
Karmefors Idvall, Moa; Tanushi, Hideyuki; Berge, Andreas; Nauclér, Pontus; van der Werff, Suzanne Desirée.
Affiliation
  • Karmefors Idvall M; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Tanushi H; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Berge A; Department of Data Processing and Analysis, Karolinska University Hospital, Stockholm, Sweden.
  • Nauclér P; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • van der Werff SD; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Antimicrob Resist Infect Control ; 13(1): 15, 2024 02 05.
Article de En | MEDLINE | ID: mdl-38317207
ABSTRACT

BACKGROUND:

Continuous surveillance for healthcare-associated infections such as central venous catheter-related bloodstream infections (CVC-BSI) is crucial for prevention. However, traditional surveillance methods are resource-intensive and prone to bias. This study aimed to develop and validate fully-automated surveillance algorithms for CVC-BSI.

METHODS:

Two algorithms were developed using electronic health record data from 1000 admissions with a positive blood culture (BCx) at Karolinska University Hospital from 2017 (1) Combining microbiological findings in BCx and CVC cultures with BSI symptoms; (2) Only using microbiological findings. These algorithms were validated in 5170 potential CVC-BSI-episodes from all admissions in 2018-2019, and results extrapolated to all potential CVC-BSI-episodes within this period (n = 181,354). The reference standard was manual record review according to ECDC's definition of microbiologically confirmed CVC-BSI (CRI3-CVC).

RESULTS:

In the potential CVC-BSI-episodes, 51 fulfilled ECDC's definition and the algorithms identified 47 and 49 episodes as CVC-BSI, respectively. Both algorithms performed well in assessing CVC-BSI. Overall, algorithm 2 performed slightly better with in the total period a sensitivity of 0.880 (95%-CI 0.783-0.959), specificity of 1.000 (95%-CI 0.999-1.000), PPV of 0.918 (95%-CI 0.833-0.981) and NPV of 1.000 (95%-CI 0.999-1.000). Incidence according to the reference and algorithm 2 was 0.33 and 0.31 per 1000 in-patient hospital-days, respectively.

CONCLUSIONS:

Both fully-automated surveillance algorithms for CVC-BSI performed well and could effectively replace manual surveillance. The simpler algorithm, using only microbiology data, is suitable when BCx testing adheres to recommendations, otherwise the algorithm using symptom data might be required. Further validation in other settings is necessary to assess the algorithms' generalisability.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infection croisée / Sepsie / Infections sur cathéters / Voies veineuses centrales Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Humans Langue: En Journal: Antimicrob Resist Infect Control Année: 2024 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infection croisée / Sepsie / Infections sur cathéters / Voies veineuses centrales Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Humans Langue: En Journal: Antimicrob Resist Infect Control Année: 2024 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni